share_log

Novavax CEO Says Cut $50M In Costs In Q1, Expects To Cut More This Year; Company In Regular Talks With U.S. FDA Over Covid-19 Shot Design, Believes Vaccine Will Be Ready For Fall

Novavax CEO Says Cut $50M In Costs In Q1, Expects To Cut More This Year; Company In Regular Talks With U.S. FDA Over Covid-19 Shot Design, Believes Vaccine Will Be Ready For Fall

Novavax首席執行官表示,第一季度削減了5000萬美元的成本,預計今年還會進一步削減成本;該公司定期與美國食品藥品管理局就Covid-19疫苗的設計進行談判,認爲疫苗將爲秋季做好準備
Benzinga ·  2023/04/13 03:30

Novavax CEO Says Cut $50M In Costs In Q1, Expects To Cut More This Year; Company In Regular Talks With U.S. FDA Over Covid-19 Shot Design, Believes Vaccine Will Be Ready For Fall

Novavax首席執行官表示,第一季度削減了5000萬美元的成本,預計今年還會進一步削減成本;該公司定期與美國食品藥品管理局就Covid-19疫苗的設計進行談判,認爲疫苗將爲秋季做好準備

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論